CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...